medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

Next >>

Rev Mex Urol 2023; 83 (1)

Considering the best study designs to evaluate healthcare interventions

García-Perdomo HA, Pineda-Cañar CA
Full text How to cite this article

Language: English
References: 5
Page:
PDF size: 172.27 Kb.


Key words:

No keywords

Text Extraction

Regarding the study published by Ramirez-Sevilla et al. in your prestigious journal, we would like to make specific comments:
Metabolic syndrome encompasses multiple diseases, such as visceral obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels (HDL-C). Multiple epidemiologic studies and meta-analyses demonstrate the association between Lower urinary tract symptoms and metabolic syndrome, according to its pathogenesis: systemic inflammation and oxidative stress.
In consequence, metabolic syndrome and all its components are risk factors for developing urinary tract infections, and this is a vital population for having the intention to prevent this deleterious condition. Hence, considering any new tool to prevent UTIs might improve these patients’ quality of life. Furthermore, in this study, inclusion criteria are vague and imprecise, and definitions are outdated. Therefore, conclusion might not be applicable nowadays.


REFERENCES

  1. Ramírez-Sevilla C, Gómez-Lanza E, Puyol-Pallàs J-M. Behavior of MV140 vaccine toprevent recurrent urinary tract infectionsin patients with metabolic syndrome andsmoking. Revista Mexicana de Urología. 2022;82(6):1–8. doi: https://doi.org/10.48193/revistamexicanadeurologa.v82i6.959

  2. He Q, Wang Z, Liu G, Daneshgari F, MacLennanGT, Gupta S. Metabolic syndrome, inflammationand lower urinary tract symptoms: possibletranslational links. Prostate Cancer Prostatic Dis.2016;19(1):7–13. doi: https://doi.org/10.1038/pcan.2015.43

  3. Dobrowolski P, Prejbisz A, Kuryłowicz A, BaskaA, Burchardt P, Chlebus K, et al. Metabolicsyndrome – a new definition and managementguidelines. A joint position paper by the PolishSociety of Hypertension, Polish Society for theTreatment of Obesity, Polish Lipid Association,Polish Association for Study of Liver, PolishSociety of Family Medicine, Polish Society ofLifestyle Medicine, Division of Prevention andEpidemiology Polish Cardiac Society, “Club 30”Polish Cardiac Society, and Division of Metabolicand Bariatric Surgery Society of Polish Surgeons.Arch Med Sci. 2022;18(5):1133–56. doi: https://doi.org/10.5114/aoms/152921

  4. Clarke GM, Conti S, Wolters AT, Steventon A.Evaluating the impact of healthcare interventionsusing routine data. BMJ. 2019;365:l2239. doi:https://doi.org/10.1136/bmj.l2239

  5. Every-Palmer S, Howick J. How evidencebasedmedicine is failing due to biased trialsand selective publication. Journal of Evaluationin Clinical Practice. 2014;20(6):908–14. doi:https://doi.org/10.1111/jep.12147




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2023;83